Inhibition of Platelet Glycoprotein Ib and Its Antithrombotic Potential

E-ISSN： 1873-4286|13|26|2684-2697

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.26, 2007-09, pp. : 2684-2697

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiaggregatory, antithrombotic effects of MS-180, a novel platelet glycoprotein II b /III a receptor antagonist

By Banno H. Kawazura H. Yutaka T. Sakuma N. Kitamori T. Hosoya J. Kibayashi K. Yamashita H. Umemura K. Nakashima M.

European Journal of Pharmacology, Vol. 367, Iss. 2, 1999-02 ,pp. : 275-282

Elsevier

Access to resources Recommend Favorite

Potential Role of Platelet Glycoprotein IIb/IIIa Antagonists in Cerebrovascular Disorders

By Mousa S.A.

CNS Drugs, Vol. 13, Iss. 3, 2000-03 ,pp. : 155-160

Adis International

Access to resources Recommend Favorite

Platelet inhibition by abciximab is reduced in patients with the A2 allele of the glycoprotein (GP) IIb/IIIa receptor

Inpharma, Vol. 1, Iss. 1328, 2002-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Therapeutic Potential of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Acute Ischaemic Stroke: Scientific Rationale and Available Evidence

By Arthur M. Pancioli

CNS Drugs, Vol. 18, Iss. 14, 2004-01 ,pp. : 981-988

Adis International

Access to resources Recommend Favorite

Therapeutic Potential of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in the Management of Ischemic Stroke

By Lapchak P.A. Araujo D.M.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 2, 2003-01 ,pp. : 87-94

Adis International

Access to resources Recommend Favorite